ArticleFrontiers in cardiovascular medicine2021

Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.

Mostafa Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.